About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Ovarian Cancer Clinical Trials | 4,055 Studies Recruiting

Clinical TrialsOvarian Cancer

Ovarian Cancer Clinical Trials

Browse 4,055 clinical trials for ovarian cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 3881-3900 of 4,055 trials

CompletedScalable Communication Modalities for Returning Genetic Research ResultsEfforts to examine the utility of alternate modalities for genetic results disclosure has widespread implications for how precision medicine research might yield direct health…NCT04407611·Boston, Massachusetts CompletedBCX-1777 in Treating Patients With Refractory CancerRATIONALE: BCX-1777 may stop the growth of cancer cells by blocking the enzymes necessary for their growth.NCT00073944·Cleveland, Ohio TerminatedImaging Tumor Hypoxia With 18F-EF5 PET in Recurrent or Metastatic Clear Cell Ovarian CancerThe purpose of this study is to use 18F-EF5 PET/CT scans to locate areas with low oxygen levels (hypoxia) in patients with recurrent and/or metastatic cancer.NCT01881451·Vancouver, British Columbia CompletedStructural and Functional Imaging and Cognitive Functions in Ovarian CancerThe purpose of this study is to learn about possible changes in brain anatomy and function, and in thinking abilities, such as memory skills, in patients with ovarian cancer who…NCT01591772·New York, New York

Related Searches

ovary cancertrials

Data from ClinicalTrials.govTerms

UnknownChromosomal Instability in Ovarian CancerChromosomal instability (CIN) refers to the ongoing genomic change, which involves the amplification or deletion of chromosome copy number or structure.NCT05310357·Beijing, Beijing Municipality

RecruitingA Randomized Controlled Trial Evaluating the Feasibility and Preliminary Efficacy of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in Advanced Epithelial Ovarian CancerEvaluation Compared with traditional NACT, whether PIPAC can increase the incidence of CRS3 determines the rationality of choosing PIPAC.NCT07544030·Changchun, Jilin

UnknownLetrozole Combined With Anlotinib Hydrochloride in the Treatment of Platinum-resistant Recurrent Ovarian CancerThe study is a prospective, single-arm, open label, exploratory phase 2 clinical trial, which aims to study the therapeutic effect of letrozole combined with anlotinib…NCT04720807·Shanghai, Shanghai Municipality

RecruitingA Study of Hansoh (HS)-10502 in Patients With Advanced Solid TumorsHS-10502 is a Poly(ADP-ribose) polymerase 1 (PARP1)-specific selective inhibitor.NCT05740956·Beijing, Beijing Municipality

CompletedEarly Chemotherapy Based on CA 125 Level Alone Compared With Delayed Chemotherapy in Treating Patients With Recurrent Ovarian Epithelial , Fallopian Tube, or Primary Peritoneal CancerRATIONALE: It is not yet known if treatment for recurrent ovarian epithelial, fallopian tube, or primary peritoneal cancer is more effective if it is begun when blood levels of CA…NCT00002895·Vienna and 20 others

CompletedA Study of DSP-7888 Dosing Emulsion in Adult Patients With Advanced MalignanciesThis is a multicenter, open label, Phase 1 dose-escalation study of DSP-7888 Dosing Emulsion administered to adult patients with advanced malignancies.NCT02498665·Denver, Colorado and 7 others

CompletedNutritional Intervention and DNA Damage of Patients With HBOCBreast and Ovarian Cancer Syndrome (HBOC) is characterized by mutations in tumor suppressor genes such as BRCA1 and BRCA2, which increase the carrier's risk of developing breast…NCT05306002·Mexico City, Benito Juárez

CompletedRapamycin With Grapefruit Juice for Advanced MalignanciesThe purpose of this study is to determine the highest safe dose of rapamycin when given with a fixed amount of grapefruit juice.NCT00375245·Chicago, Illinois

CompletedA Pilot Study Investigating the Effect of Chemotherapy on the Tumoral Immunoprofile of Gynecologic CancersThe investigators propose to collect biologic samples (i.e. tumor tissue, ascites, and/or blood), from patients undergoing standard of care therapy for a gynecologic malignancy.NCT02824328·Durham, North Carolina

CompletedMM-398 (Nanoliposomal Irinotecan, Nal-IRI) to Determine Tumor Drug Levels and to Evaluate the Feasibility of Ferumoxytol Magnetic Resonance Imaging to Measure Tumor Associated Macrophages and to Predict Patient Response to TreatmentThis is a Phase I study to understand the biodistribution of MM-398 and to determine the feasibility of using Ferumoxytol as a tumor imaging agent.NCT01770353·Scottsdale, Arizona and 6 others

CompletedCaptopril in Treating Patients Undergoing Bone Marrow or Stem Cell TransplantationRATIONALE: Captopril may protect the lungs from the side effects of bone marrow or stem cell transplantation.NCT00004230·Chicago, Illinois

UnknownA Prospective, Randomized Controlled Study of Cyclophosphamide, Bevacizumab With or Without Envafolimab in Recurrent Epithelial Ovarian Cancer (EOC), Fallopian Tube Cancer, and Primary Peritoneal CancerThe primary objective of this study is to evaluate the efficacy and safety of cyclophosphamide and bevacizumab in combination with Envafolimab in the treatment of recurrent…NCT06010667·Shijiazhuang, Hebei

CompletedBreast Cancer Risk After Diagnostic Gene SequencingStudy of the psychological impact of breast cancer risk communication in Cancer Genetics based on the personalized estimation of the BOADICEA V5/PLUS model ("Breast and Ovarian…NCT04145817·Paris and 1 other

CompletedA Study to Assess the Safety and Pharmacokinetics of an Inhibitor of Poly ADP-Ribose Polymerase-1 (PARP)To determine the safety, tolerability, dose-limiting toxicity (DLT), pharmacokinetic-pharmacodynamic profile, and maximum tolerated dose (MTD) of KU-0059436 when administered…NCT00516373·Brussels and 4 others

RecruitingA Phase 1 Study to Evaluate OPB-201 in Recurrent Endometrial and Platinum-resistant Ovarian Cancer.The goal of this clinical trial is to learn if OPB-201 is safe in recurrent endometrial and platinum resistant ovarian cancer participants and also to find the optimal dose of…NCT07664735·San Francisco, California and 4 others

RecruitingTrial of THEO-260 in Ovarian Cancer PatientsA research study evaluating a new oncolytic virus, THEO-260, in patients with advanced ovarian cancer.NCT06618235·Madrid and 3 others

PreviousPage 195 of 203Next